ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)
Clinical trial NCT05279417 · COMPLETED
Trial details
- NCT number
- NCT05279417
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2023-09-05
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.